Grant Development & Funding Opportunities

The Novel Methodologies and Pilot Studies program promotes new avenues for translational research by fostering relationships and collaborations to engage researchers and by administering the Translational Research Institute’s (TRI) pilot funding program. The TRI seeks to fund translational research at all levels from basic science to clinical trials of new therapeutics that will result in community-based interventions that improve the health of the population.

Rainmaker Consultation
Obtain guidance on building collaborations, identifying funding, developing research ideas and writing proposals.

TRI Funding Opportunities
View a list of TRI’s current funding opportunities, including the three mainstay programs:

Other Funding Opportunities

Program Leadership

Samuel Michael Owens, Ph.D. | Biography
Director
owenssamuelm@uams.edu
501-686-5487
Sudhir Shah, M.D. | Biography
Co-Director
shahsudhirv@uams.edu
501-257-5832
Bulloch_Kelly Kelly Bulloch, J.D.
Program Manager
kwbulloch@uams.edu
501-686-5417

The Translational Research Institute (TRI) at the University of Arkansas for Medical Sciences (UAMS) is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, grants UL1TR000039 and KL2TR000063. The CTSA program is led by the NIH’s National Center for Advancing Translational Sciences (NCATS). The content of this website is solely the responsibility of UAMS and does not necessarily represent the official views of the NIH.

All publications, patents, projects, etc., resulting from the utilization of TRI resources are required to credit the TRI grant by including the NIH Funding Acknowledgment and must comply with NIH Public Access Policy.